These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15146996)

  • 1. Stimulation of the immune system by different TBE-virus vaccines.
    Marth E; Kleinhappl B; Jelovcan S
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():139-44. PubMed ID: 15146996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination.
    Marth E; Kleinhappl B
    Vaccine; 2001 Nov; 20(3-4):532-7. PubMed ID: 11672919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.
    Beran J; Douda P; Gniel D; Zent O
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():130-3. PubMed ID: 15146994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
    Wittermann C; Schöndorf I; Gniel D
    Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
    Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
    Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude and Functional Profile of the Human CD4
    Varnaitė R; Blom K; Lampen MH; Vene S; Thunberg S; Lindquist L; Ljunggren HG; Rombo L; Askling HH; Gredmark-Russ S
    J Immunol; 2020 Feb; 204(4):914-922. PubMed ID: 31924650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immunogenicity and safety between two paediatric TBE vaccines.
    Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Prymula R; Angermayr R; Draxler W; Firth C; Bosman J; Valenta B; Harmacek P; Maritsch F; Barrett PN; Ehrlich HJ
    Vaccine; 2010 Jun; 28(29):4680-5. PubMed ID: 20433803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Active immunization against tick-born encephalitis (TBE) among border guards (1993-2002)].
    Knap J; Ryba S
    Przegl Epidemiol; 2002; 56 Suppl 1():110-6. PubMed ID: 12194224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
    Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
    Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
    Zent O; Schwarz TF; Plentz A; Banzhoff A; Jilg W
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():134-8. PubMed ID: 15146995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
    Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
    Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
    Steffen R; Erber W; Schmitt HJ
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
    Zent O; Banzhoff A; Hilbert AK; Meriste S; Słuzewski W; Wittermann Ch
    Vaccine; 2003 Sep; 21(25-26):3584-92. PubMed ID: 12922086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.
    Beck Y; Fritz R; Orlinger K; Kiermayr S; Ilk R; Portsmouth D; Pöllabauer EM; Löw-Baselli A; Hessel A; Kölch D; Howard MK; Barrett PN; Kreil TR
    J Virol; 2016 Feb; 90(4):1964-72. PubMed ID: 26656681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
    Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.